글로벌 생식 서비스 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

생식 서비스 시장 분석  

불임 치료 서비스 시장은 불임률 증가, 보조 생식 기술(ART)의 발전, 생식 건강에 대한 인식 증가가 결합되어 강력한 성장을 목격하고 있습니다. 이 부문의 주목할 만한 발전에는 배아의 유전적 질환을 선별하여 시험관 수정(IVF)의 성공률을 개선하는 착상 전 유전자 검사(PGT)와 같은 최첨단 기술의 통합이 포함됩니다. 또한, 이 시장은 환자가 집에서 편안하게 불임 상담과 치료에 접근할 수 있도록 하는 원격 의료 서비스의 증가를 목격했습니다. 특히 출산을 연기하고자 하는 젊은 여성들 사이에서 불임 보존 방법에 대한 수용이 증가하면서 시장 환경도 형성되고 있습니다. 게다가, 불임 치료 클리닉과 생명공학 회사 간의 협력은 불임 치료의 혁신을 촉진하여 개인의 요구에 맞는 개인화된 솔루션으로 이어지고 있습니다. 이러한 발전으로 불임 치료 서비스 시장은 지속적인 성장을 향해 나아가고 있으며, 환자의 변화하는 요구에 부응하고 전반적인 생식 건강 생태계를 개선할 준비가 되어 있습니다.

생식 서비스 시장 규모

글로벌 불임 치료 서비스 시장 규모는 2023년에 202억 4천만 달러로 평가되었으며, 2031년까지 366억 3천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.70%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

생식 서비스 시장 동향

“ 생식력 보존에 대한 수요 증가”

불임 치료 서비스 시장은 불임률 증가와 생식 건강에 대한 인식 증가로 인해 상당한 성장을 경험하고 있습니다. 특히, 시험관 수정(IVF)과 같은 보조 생식 기술(ART)은 임신에 어려움을 겪는 부부에게 효과적인 솔루션으로 인기를 얻고 있습니다. 시장에서 주목할 만한 추세는 특히 직장이나 개인적인 이유로 출산을 미루는 여성들 사이에서 생식력 보존에 대한 수요가 증가하고 있다는 것입니다. 예를 들어, 많은 병원에서는 여성이 생식 옵션을 유지할 수 있도록 돕기 위해 난자 동결 서비스를 제공합니다. 또한 유전자 검사와 배아 선택 기술의 발전으로 성공률이 향상되어 ART가 더욱 매력적으로 보입니다. 결과적으로, 다양한 환자 요구에 부응하는 혁신적인 솔루션에 대한 투자가 증가함에 따라 불임 치료 서비스 시장이 더욱 확대될 것으로 예상됩니다. 이러한 성장은 생식 건강을 우선시하고 개인에게 가족을 꾸리는 데 필요한 도구와 지원을 제공하는 방향으로 사회적으로 더욱 광범위하게 변화하고 있음을 보여줍니다.

보고서 범위 및 생식 서비스 시장 세분화    

Fertility Services Market Definition

Fertility services refer to a comprehensive range of medical treatments and interventions designed to assist individuals and couples in achieving pregnancy. These services include diagnostic testing to identify fertility issues, assisted reproductive technologies (ART) such as in vitro fertilization (IVF) services and intrauterine insemination (IUI), as well as fertility preservation techniques such as egg or sperm freezing. In addition, fertility services often provide counseling and support to help individuals navigate the emotional challenges associated with infertility, ultimately aiming to enhance reproductive health and facilitate family planning.

Fertility Services Market Dynamics

Drivers

• Rising Infertility Rates

Rising infertility rates among couples are a significant driver of demand for fertility services, influenced by factors such as delayed marriage, lifestyle choices, and environmental factors. According to the World Health Organization (WHO), approximately 15% of couples globally experience infertility, with the prevalence rising due to changing societal norms, where individuals often prioritize education and career before starting families. In addition, lifestyle factors, such as unhealthy diets, increased stress levels, and rising obesity rates, further contribute to fertility challenges. For instance, the American Society for Reproductive Medicine (ASRM) reports that conditions such as polycystic ovary syndrome (PCOS) and male infertility are becoming more common, exacerbating the need for assisted reproductive technologies. As couples face these challenges, the demand for fertility services continues to grow, driving innovations and expansions in the market.

• Growing Market for Egg Freezing

The growing market for egg freezing is a significant driver in the fertility services sector, reflecting changing societal norms and increasing awareness among women about their reproductive options. According to the American Society for Reproductive Medicine (ASRM), egg freezing cycles increased to 29,803, up from 24,560 in 2021. Additionally, advancements in freezing technologies, such as vitrification, have significantly improved the success rates of thawing frozen eggs, further encouraging women to consider this option. As more fertility clinics offer egg freezing services and provide educational resources, this growing awareness is likely to drive demand, making egg freezing a key component of the fertility services market, thereby driving the market growth.

Opportunities

• Increasing Awareness Regarding In Vitro Fertilization (IVF)

The increase in awareness regarding in vitro fertilization (IVF) is creating significant opportunities within the global fertility services market. As more individuals and couples become informed about the benefits of IVF, particularly in addressing infertility challenges, the demand for these services has surged. Educational initiatives, social media campaigns, and success stories shared by patients are helping to demystify the IVF process and reduce stigma surrounding fertility treatments. For instance, organizations such as the American Society for Reproductive Medicine (ASRM) provide resources and information that empower couples to make informed decisions about their reproductive health. Additionally, the rise of fertility clinics offering comprehensive services, such as egg freezing and fertility preservation, caters to the evolving needs of patients, especially those delaying parenthood for personal or professional reasons. This heightened awareness and acceptance of IVF, combined with advancements in reproductive technologies, is expected to drive significant growth in the global fertility services market, creating new opportunities for service providers and innovators in the field.

• Increasing Advancements in Genetic Testing

Advancements in technology are revolutionizing the fertility services market, particularly through innovations in assisted reproductive technologies (ART) that enhance success rates and attract a growing patient base. For instance, Advancements in genetic testing, such as preimplantation genetic testing for aneuploidy (PGT-A), allow for the screening of embryos for chromosomal abnormalities before implantation, further increasing the likelihood of successful pregnancies. As these technologies become more widely adopted, fertility clinics that integrate them into their practice can significantly improve patient outcomes and satisfaction, thus positioning themselves competitively in a rapidly evolving market. This technological evolution fosters patient trust and opens new opportunities for clinics focused on providing cutting-edge fertility solutions.

Restraints/Challenges

• High Treatment Costs

High treatment costs present a substantial challenge in the fertility services market, as the expenses associated with procedures such as In-Vitro Fertilization (IVF) and other assisted reproductive technologies can be prohibitively high for many patients. The financial burden can lead to significant stress for couples trying to conceive, especially since multiple treatment cycles are often needed for success. Furthermore, many insurance plans do not cover fertility treatments, limiting access for a considerable portion of the population. This lack of coverage disproportionately affects low- and middle-income individuals, who may be forced to make difficult decisions regarding their reproductive health. As a result, high treatment costs hinder access to essential medical care and contribute to growing disparities in reproductive health outcomes.

• Ethical Concerns Surrounding Assisted Reproductive Technologies

Ethical concerns surrounding assisted reproductive technologies (ART) represent a significant challenge in the fertility services market, as they encompass various implications related to genetic testing, embryo selection, and the use of donor gametes. For instance, the practice of embryo selection, which involves choosing embryos with the highest likelihood of successful implantation based on genetic profiling, raises questions about "designer babies" and the moral implications of selecting traits. These ethical dilemmas can create hesitancy among potential patients, as individuals may grapple with the moral considerations of their choices regarding reproduction. In addition, public backlash can arise against certain practices, leading to increased scrutiny and potential regulatory restrictions on ART. Such ethical complexities can deter individuals from seeking fertility treatments, ultimately impacting market growth and the willingness of healthcare providers to offer certain services, thereby presenting a notable challenge within the fertility services sector.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Fertility Services Market Scope

The market is segmented on the basis of infertility, procedure, services, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diagnosis
• Male infertility
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others
• Female infertility
  • Ovarian reserve testing
  • Hysterosalpingography
  • Hormone testing
  • Other Tests
• Treatment
  • In-Vitro Fertilization (IVF)
  • Artificial Insemination
• Preservation
  • Egg & Embryo Freezing
  • Sperm Banking

Procedure

• Assisted Reproductive Technology (ART)
• In-Vitro Fertilization (IVF)
• Artificial Insemination
• Surrogacy
• Others

Services

• Donor services
• Non-donor services

End-User

• Fertility clinics
• Hospitals
• Clinical research institutes
• Surgical centers

Fertility Services Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, infertility, procedure, services, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the fertility services market, driven by several key factors, including declining fertility rates and a rising median age of motherhood. As more women delay childbirth for various reasons, the demand for fertility services has increased significantly. In addition, the growing prevalence of obesity in the region further contributes to fertility challenges, prompting individuals and couples to seek assisted reproductive technologies and related services to enhance their chances of conception.

Asia-Pacific region is projected to experience the highest growth rate from 2022 to 2029, driven primarily by a notable decline in fertility rates. This trend not only impacts demographic dynamics but also influences healthcare demand and resource allocation. As a result, the region's healthcare sector is expected to adapt to changing population needs and preferences, fostering innovation and investment opportunities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Fertility Services Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Fertility Services Market Leaders Operating in the Market Are:

• Olympus Corporation (Japan)
• The Cooper Companies Inc. (U.S.)
• Instituto Bernabeu (Spain)
• VirtusHealth (Australia)
• CooperSurgical, Inc. (U.S.)
• Vitrolife (Sweden)
• Care Fertility (U.K.)
• INVO Bioscience (U.S.)
• Monash IVF (Australia)
• Fertility Focus Limited (U.S.)
• Carolinas Fertility Institute (U.S.)
• Apollo Hospitals Enterprise Ltd. (India)
• Merck KGaA (Germany)
• LABOTECT GMBH (Germany)
• Medicover AB (Sweden)

Latest Developments in Fertility Services Market

• In June 2023, Quantum Health formed a partnership with Progyny, Inc. to launch Quantum Health's Comprehensive Care Solutions platform, specifically designed to provide family building and fertility solutions. This collaboration aims to enhance access to fertility services, offering a streamlined approach to care that supports individuals and couples on their journey to parenthood
• In April 2023, Cryoport, Inc. entered into a three-year supply chain agreement with Boston IVF to facilitate the shipment of reproductive materials across the United States. This partnership is intended to ensure the safe and timely transport of critical biological samples, such as eggs, sperm, and embryos, which are essential for fertility treatments
• In October 2022, Maven Clinic, a U.S.-based company specializing in telemedicine and virtual clinic services for women’s and family health, partnered with Indira IVF, an India-based infertility specialty clinic chain. This collaboration aims to extend access to Indira IVF's high-quality clinical care to Maven's members in India, enhancing the support available for family-building needs
• 2021년 7월, ART 연구의 글로벌 공급업체인 Hamilton Throne Ltd.는 IVFTECH ApS(IVFtech)와 그 계열사인 K4 Technology ApS를 인수했습니다. 이 인수는 K4 Technology의 리소스와 전문성을 활용하여 보조 생식 기술(ART)을 위한 층류 워크스테이션과 대용량 인큐베이터를 제공하려는 IVFtech의 의지를 강화합니다. 이들은 함께 업계에서 ART 솔루션의 품질과 효율성을 향상시키는 것을 목표로 합니다.
• 2021년 5월, 보조 생식 서비스(ARS) 분야의 글로벌 리더인 Virtus Health는 만성 염증을 전문으로 하는 호주의 생명공학 및 디지털 건강 회사인 Drop Bio와의 전략적 파트너십을 발표했습니다. 이 협력은 정밀 생식의 발전을 강화하고 두 회사의 전문성을 활용하여 생식 결과를 개선하고 개별 환자의 요구에 맞게 치료를 맞춤화하는 것을 목표로 합니다.
• 2020년 6월, Ferring BV와 Igenomix는 임신 관련 질환 치료를 위한 혁신적인 치료제 개발에 중점을 둔 4년 연구 협업을 수립했습니다. 이 파트너십은 Ferring의 생식 의학 전문성과 Igenomix의 최첨단 유전자 분석 역량을 결합합니다.

SKU-29201